Search research articles
Contact Us
Filters
Showing results (41-50 of 167) with videos related to
Page
of 17
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2022
Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia
Owen R Albin, Keith S Kaye, Erin K McCreary, et al.
American Journal of Infection Control
|
April 30, 2014
Extended-spectrum β-lactamase-producing Escherichia coli isolation among older adults: epidemiology and outcomes
Sameen Farooq, Kayoko Hayakawa, Dror Marchaim, et al.
Infection Control and Hospital Epidemiology
|
May 3, 2021
Asymptomatic bacterisputia: Rethinking diagnostic stewardship in pneumonia
Owen R Albin, Jason M Pogue, Lindsay A Petty, et al.
Infectious Disease Clinics of North America
|
August 13, 2016
Antimicrobial Stewardship for the Infection Control Practitioner
Jerod L Nagel, Keith S Kaye, Kerry L LaPlante, et al.
Pharmacotherapy
|
October 24, 2021
The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists
Marguerite L Monogue, Emily L Heil, Samuel L Aitken, et al.
Open Forum Infectious Diseases
|
July 1, 2015
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
Haley J Morrill, Jason M Pogue, Keith S Kaye, et al.
Future Microbiology
|
April 26, 2018
Meropenem-vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria
Twisha S Patel, Jason M Pogue, John P Mills, et al.
Infection Control and Hospital Epidemiology
|
November 13, 2007
Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus
Jason M Pogue, David L Paterson, A William Pasculle, et al.
Expert Review of Anti-Infective Therapy
|
February 10, 2015
Therapeutic options for vancomycin-resistant enterococcal bacteremia
Katie E Barber, S Travis King, Kayla R Stover, et al.
Antimicrobial Agents and Chemotherapy
|
November 19, 2025
Unlocking potentials: the impact of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam in combating carbapenem-resistant <i>Enterobacter cloacae</i>
Thomas Lavoie, Teresa Sierra, Katie Daffinee, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 167) with videos related to
Sort By:
Page
of 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2022
Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia
Owen R Albin, Keith S Kaye, Erin K McCreary, et al.
American Journal of Infection Control
|
April 30, 2014
Extended-spectrum β-lactamase-producing Escherichia coli isolation among older adults: epidemiology and outcomes
Sameen Farooq, Kayoko Hayakawa, Dror Marchaim, et al.
Infection Control and Hospital Epidemiology
|
May 3, 2021
Asymptomatic bacterisputia: Rethinking diagnostic stewardship in pneumonia
Owen R Albin, Jason M Pogue, Lindsay A Petty, et al.
Infectious Disease Clinics of North America
|
August 13, 2016
Antimicrobial Stewardship for the Infection Control Practitioner
Jerod L Nagel, Keith S Kaye, Kerry L LaPlante, et al.
Pharmacotherapy
|
October 24, 2021
The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists
Marguerite L Monogue, Emily L Heil, Samuel L Aitken, et al.
Open Forum Infectious Diseases
|
July 1, 2015
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
Haley J Morrill, Jason M Pogue, Keith S Kaye, et al.
Future Microbiology
|
April 26, 2018
Meropenem-vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria
Twisha S Patel, Jason M Pogue, John P Mills, et al.
Infection Control and Hospital Epidemiology
|
November 13, 2007
Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus
Jason M Pogue, David L Paterson, A William Pasculle, et al.
Expert Review of Anti-Infective Therapy
|
February 10, 2015
Therapeutic options for vancomycin-resistant enterococcal bacteremia
Katie E Barber, S Travis King, Kayla R Stover, et al.
Antimicrobial Agents and Chemotherapy
|
November 19, 2025
Unlocking potentials: the impact of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam in combating carbapenem-resistant <i>Enterobacter cloacae</i>
Thomas Lavoie, Teresa Sierra, Katie Daffinee, et al.
Page
of 17